Home/Filings/4/0001470831-25-000349
4//SEC Filing

Apuli Maricel 4

Accession 0001470831-25-000349

CIK 0001743881other

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 7:23 PM ET

Size

4.9 KB

Accession

0001470831-25-000349

Insider Transaction Report

Form 4
Period: 2025-11-16
Apuli Maricel
Chief Accounting Officer
Transactions
  • Tax Payment

    Common Stock

    2025-11-16$66.39/sh4,781$317,411132,297 total
Footnotes (1)
  • [F1]Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 9,410 shares of Common Stock underlying the Reporting Person's Restricted Stock Units.

Issuer

BridgeBio Pharma, Inc.

CIK 0001743881

Entity typeother

Related Parties

1
  • filerCIK 0002058197

Filing Metadata

Form type
4
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 7:23 PM ET
Size
4.9 KB